Determinants of Neonatal Mortality in Bhutan: A Case-Control Study.


Journal

Asia-Pacific journal of public health
ISSN: 1941-2479
Titre abrégé: Asia Pac J Public Health
Pays: China
ID NLM: 8708538

Informations de publication

Date de publication:
11 2023
Historique:
medline: 15 11 2023
pubmed: 16 10 2023
entrez: 16 10 2023
Statut: ppublish

Résumé

More than half of Bhutan's under-five mortality is attributed to neonatal deaths. Despite this, there is a lack of local evidence on determinants of neonatal mortality. It is critical to generate new evidence to accelerate interventions to achieve sufficient reduction of neonatal mortality rate in line to sustainable development goal target 3.2. Thus, this study was aimed at exploring determinants of neonatal mortality in Bhutan. A case-control study was performed with reported neonatal deaths from hospitals and primary health centers between 2018 and 2019. A total of 181 neonatal deaths were included as cases along with three corresponding controls. Epidata and STATA were used for data management and analysis, respectively. A multivariable model was fitted to identify determinants of neonatal mortality. History of obstetric complications (odds ratio [OR] = 3.53; 95% confidence interval [CI] = 1.48-8.42), intrapartum complications (OR = 3.86; 95% CI = 1.71-8.74) gestational age (OR = 8.07; 95% CI = 2.89-22.52), and Apgar 1 minute (OR = 4.40; 95% CI =1.83-10.59) were associated with neonatal death. Therefore, quality of care during pregnancy and childbirth besides promoting supportive family environment is essential to reduce neonatal mortality.

Identifiants

pubmed: 37842840
doi: 10.1177/10105395231203112
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

486-493

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Pema Lethro (P)

University of Western Australia, Perth, Australia.
Ministry of Health, Thimphu, Bhutan.
Royal Institute of Management, Thimphu, Bhutan.

Yoriko Nishizawa (Y)

School of Medicine, University of Fukui, Fukui, Japan.
Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi, Japan.

Kinley Dorjee (K)

College of Natural Resources, Lobesa, Bhutan.

Kencho Zangmo (K)

Burapha University, Thailand.
Rajiv Gandhi University of Health Sciences, Karnataka, India.

Lobzang Dorji (L)

University of Sydney, Sydney, Australia.
MAG Osmani Medical College, Bangladesh.

Karma Tenzin (K)

Royal Institute of Management, Thimphu, Bhutan.
Sherubtse College, Kanglung, Bhutan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH